These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38727016)

  • 1. Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules.
    Bassani D; Parrott NJ; Manevski N; Zhang JD
    Expert Opin Drug Discov; 2024 Jun; 19(6):683-698. PubMed ID: 38727016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans.
    Li Y; Wang Z; Li Y; Du J; Gao X; Li Y; Lai L
    Pharm Res; 2024 Jul; 41(7):1369-1379. PubMed ID: 38918309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the use of machine learning for ADME prediction at AstraZeneca.
    Gawehn E; Greene N; Miljković F; Obrezanova O; Subramanian V; Trapotsi MA; Winiwarter S
    Xenobiotica; 2024 Jul; 54(7):368-378. PubMed ID: 39166404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical Structure.
    Obrezanova O; Martinsson A; Whitehead T; Mahmoud S; Bender A; Miljković F; Grabowski P; Irwin B; Oprisiu I; Conduit G; Segall M; Smith GF; Williamson B; Winiwarter S; Greene N
    Mol Pharm; 2022 May; 19(5):1488-1504. PubMed ID: 35412314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery.
    Lucas AJ; Sproston JL; Barton P; Riley RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1313-1327. PubMed ID: 31538500
    [No Abstract]   [Full Text] [Related]  

  • 6. Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure.
    Pillai N; Abos A; Teutonico D; Mavroudis PD
    Clin Transl Sci; 2024 May; 17(5):e13824. PubMed ID: 38752574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based Target Pharmacology Assessment (mTPA): An Approach Using PBPK/PD Modeling and Machine Learning to Design Medicinal Chemistry and DMPK Strategies in Early Drug Discovery.
    Chen EP; Bondi RW; Michalski PJ
    J Med Chem; 2021 Mar; 64(6):3185-3196. PubMed ID: 33719432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.
    Jones HM; Mayawala K; Poulin P
    AAPS J; 2013 Apr; 15(2):377-87. PubMed ID: 23269526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.
    Chou WC; Lin Z
    Toxicol Sci; 2023 Jan; 191(1):1-14. PubMed ID: 36156156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of PBPK modelling in drug discovery and development at Pfizer.
    Jones HM; Dickins M; Youdim K; Gosset JR; Attkins NJ; Hay TL; Gurrell IK; Logan YR; Bungay PJ; Jones BC; Gardner IB
    Xenobiotica; 2012 Jan; 42(1):94-106. PubMed ID: 22035569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
    Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
    Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational modeling of human oral bioavailability: what will be next?
    Cabrera-Pérez MÁ; Pham-The H
    Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine.
    Paliwal A; Jain S; Kumar S; Wal P; Khandai M; Khandige PS; Sadananda V; Anwer MK; Gulati M; Behl T; Srivastava S
    Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):181-195. PubMed ID: 38480460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
    Rostami-Hodjegan A
    Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance.
    Keefer CE; Chang G; Di L; Woody NA; Tess DA; Osgood SM; Kapinos B; Racich J; Carlo AA; Balesano A; Ferguson N; Orozco C; Zueva L; Luo L
    Mol Pharm; 2023 Nov; 20(11):5616-5630. PubMed ID: 37812508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction prediction.
    Gill J; Moullet M; Martinsson A; Miljković F; Williamson B; Arends RH; Pilla Reddy V
    CPT Pharmacometrics Syst Pharmacol; 2022 Dec; 11(12):1560-1568. PubMed ID: 36176050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
    Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
    J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
    Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
    Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
    Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds.
    Mao J; Ma F; Yu J; Bruyn T; Ning M; Bowman C; Chen Y
    Biopharm Drug Dispos; 2023 Aug; 44(4):315-334. PubMed ID: 37160730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.